id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-D-4318-0001,FDA,FDA-2016-D-4318,"Compounding and Repackaging of Radiopharmaceuticals by State-
Licensed Nuclear Pharmacies and Federal Facilities; Draft Guidance for
Industry; Availability",Notice,Notice of Availability,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T14:29:37Z,2016-31513,0,0,090000648243d2fb
FDA-2016-D-4318-0002,FDA,FDA-2016-D-4318,"Compounding and Repackaging of Radiopharmaceuticals by State-Licensed Nuclear Pharmacies and Federal Facilities Guidance for Industry
DRAFT GUIDANCE",Other,Guidance,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,2017-02-28T04:59:59Z,2024-11-12T06:15:53Z,,1,0,090000648243dd0f